In addition, a group of patients treated with intranasal Nasonex(R) (mometasone furoate monohydrate) did not show symptom improement compared to placebo during the eight hour study period.

• 另外，一组患者给予鼻腔内部内舒拿（莫米松安特酰胺一水化合物）治疗，在8小时研究期间内与安慰剂组相对照比较未显示症状改善。